Recital 6, Decision_act (EU) 2022/866

In forcesince 25 May 2022

Article 19(1), point (b)(iii), of Regulation (EU) No 528/2012 indicates as one of the criteria for granting an authorisation that the biocidal product has no unacceptable effects itself, or as a result of its residues, on the health of humans.